Fennec Pharmaceuticals Inc. (FENC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 220.04M |
| Enterprise Value | 183.32M |
| P/E Ratio | -84.08 |
| PEG Ratio | -1.5 |
| Price/Sales Ratio | 6.47 |
| Price/Book Ratio | 8.9 |
| Enterprise/Revenue | 5.78 |
| Enterprise/EBITDA | -143.89 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.05 |
| Operating Margin | -0.02 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.12 |
Income Statement
| Revenue | 44.64M |
| Revenue/Share | 1.71 |
| Gross Profit | 40.88M |
| EBITDA | -7.45M |
| Net Income | -9.74M |
| Diluted EPS | -0.36 |
Balance Sheet
| Total Cash | 41.25M |
| Total Cash/Share | 1.19 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.85 |
| Book Value Per Share | 1.23 |
Price History
| 52-Week Change | 39.85 |
| 52-Week High | 13.25 |
| 52-Week Low | 5.65 |
| Moving Average 50 Days | 10.69 |
| Moving Average 200 Days | 9.31 |
Statistics
| Average Volume | 179,345 |
| Shares Outstanding | 35.07M |
| % Held by Institutions | 47.44 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | September 09, 2014 |
AD
